Queen Mary University of London
Charterhouse Square, United Kingdom
University in London, England
Barbican, London EC1M 6BQ
About Queen Mary University of London
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
2
Clinical Trials at Queen Mary University of London
During the past decade, Queen Mary University of London conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
2018-04-17
2024-04-05
Active, not recruiting
211
A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
2020-07-02
2025-04-04
Recruiting
85
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Mary University of London"
#1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Queen Mary University of London
According to Clinical.Site data, the most researched conditions in "Queen Mary University of London" are
"Leukemia, Lymphocytic, Chronic, B-Cell" (2 trials) and "Lymphoma, Non-Hodgkin" (1 trials). Many other conditions were trialed in "Queen Mary University of London" in a lesser frequency.
Clinical Trials Intervention Types at Queen Mary University of London
Most popular intervention types in "Queen Mary University of London" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Chlorambucil" (1 trials), "Ibrutinib" (1 trials), "Ibrutinib (as Subsequent Therapy)" (1 trials), "JNJ-64264681" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Queen Mary University of London
The vast majority of trials in "Queen Mary University of London" are
2 trials for "All" genders.
Clinical Trials Status at Queen Mary University of London
Currently, there are NaN active trials in "Queen Mary University of London".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Queen Mary University of London,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Queen Mary University of London, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".